Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Build a KOL Community Virtually – Engaging Your Advisors Creatively

October 9, 2025 | Community board, HCP Discussion, HCP engagement, HCP forum, Impetus Digital, KOL community board, KOL virtual community, MCL relationships, Pharma community, Pharma tips, Pharma trends, Virtual Engagement, advisor engagement, discussion forum, life science community, peer to peer sharing, virtual advisor 

Go beyond formal meetings! Discover a creative way to build a virtual KOL community through ongoing discussion forums. Facilitate peer-to-peer best practice sharing and foster authentic, sustained relationships with your advisors.

Discover how to sustain engagement and build long-term relationships with your advisors. Explore the power of ongoing HCP discussion forums as a supplement to formal advisory touchpoints. Learn how keeping a dialogue forum open for peer-to-peer best practice sharing helps your advisors feel part of a valuable community of KOLs, fostering authentic relationships and continuous engagement.

  1. Ongoing HCP Discussion Forums
    • Use open forums to facilitate peer-to-peer best practice-sharing among advisors.
    • Help advisors feel like part of a long-term community and build authentic relationships.
    • Facilitate ongoing communication between various stakeholders (e.g., MSLs and clinicians).
    • Understand how this approach supplements, but does not replace, formal touchpoints.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Ten ways to start (or continue) your patient engagement journey

Here are 10 easy approaches Pharma teams can take when starting (or continuing) their patient engagement journey!

Increased Timeliness to Insight-gathering and Output Delivery in Virtual Advisory Boards

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on...

Top 10 benefits of virtual advisory boards: Increased Engagement and Insights

#2. Increased Advisor Engagement and Quality and Quantity of Insights

Top 10 benefits of virtual advisory boards: Save Time and Resources

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #1. Countless Hours of Time-savings and Substantially Reduced Costs We’ll...

10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Strengths and Weaknesses of Your Product

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Messaging and Branding

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Key Brand Attributes

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's the first one to keep...

Top 10 Most Important Advisor Questions: Unmet Needs

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's the first one to keep...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...